Food Additives and Contaminants

Chemicals may be added to foods for a number of reasons.  Typically, these reasons may be broadly classified as consumer-related or distributor-related.  However, the goals of each group may be closely intertwined and the distinctions are often less obvious upon close examination of food distribution and purchase.

There are numerous difficulties that may be encountered by toxicologists in assessing the potential harm that may come from food additives.  These are due to the inadequacies and complications of animal models and the variability of human exposure.  Typically, testing for food additive toxicity is designed so that the additive is administered to an animal model for the life of that animal in a range of doses, of which the highest dose is much greater than that expected to occur during the course of human exposure.  Problems that arise with animal testing include Tartrazine -- an orange dye used as a colouring agent in foods (especially orange juices) and drugs.  Tartrazine has been associated with two distinct types of adverse reactions. Saccharin -- This artificial sweetener was developed in the 19th century.  It is a better sweetener than other compounds (cyclamate) in that there is very little aftertaste.  It is know to produce bladder cancer in laboratory animals (cyclamate also produces bladder cancer, at a higher incidence).  However, this occurred in studies which utilised an extremely high dose (much higher than any that could be consumed by humans during a normal lifespan) that resulted in saturation of the elimination pathways, causing an even higher body burden of saccharin.  Saccharin was added to food products prior to this effect being published.  When the correlation with bladder cancer became known, the additive was removed from the market in accordance with the Delaney Clause of the Food and Drug Act, which prohibited the use of any known carcinogen as a food additive.  However, public outcry and lobbying efforts from diabetic support groups, resulted in the FDA reviewing the data and placing a moratorium on the law, permitting its use as an artificial sweetener.  This particular situation illustrates the risk:benefit ratio that is often analysed in determining whether or not to allow a toxic compound on the market.

Monosodium Glutamate (MSG) -- This compound is used as a flavour enhancer in prepared foods and restaurants.  There is a relatively high incidence of mild reaction to the additive.  In these people it most often produces a "pressure" in the head, "tightness" in the face, headache, and facial flushing.  It has occasionally produced seizures in epileptic individuals.  Extremely high doses have been shown to produce hypothalamic and retinal lesions and reproductive toxicity in both males and females.

Aflatoxin -- This mycotoxin may present as a food contaminant.  It is produced by the mould Aspergillus, which may grow on legumes (peanuts) and grains (corn).  Testing for Aspergillus is routine in the U.S.A. (exposure to ultraviolet light will expose the fungus) and batches of grain that contain the mould are destroyed.  Additionally, there are strict import requirements which reduce the incidence of aflatoxin toxicity.  The toxicity was discovered when turkeys were fed forage that had been infected with Aspergillus and later developed liver tumours.  The toxicity presents as both hepatoxicity (liver failure) and liver cancer.  Mechanistically, both effects are thought to be mediated by an epoxide intermediary.  Another example of "natural" foods that may be more toxic than processed is the case where peanut butter that had not been processed (the peanuts were not treated with a fungicide) was contaminated with aflatoxin, which resulted in hepatoxicity.

Case Study, The Spanish Oil Syndrome -- This food contamination incident is a classic case involving widespread toxicity to a contaminated food product.  It occurred in 1981 around Madrid, Spain and affected over 20,000 persons with at least 351 deaths.  The cases presented acutely with transient, severe pulmonary œdema, exanthema, and eosinophilia (there was a two-week latency before the onset of these symptoms, but this was not discovered until the causative agent was identified).  The patients then demonstrated a second, chronic phase of toxicity that presented with muscle atrophy, skin lesions, weight loss, and vasculitis.  The chain of events appears to be that rapeseed (canola) oil was imported into Spain.  As prescribed by Spanish law, it was adulterated with aniline and therefore was not suitable for consumption as a food.  It was then refined and sold as cooking oil (apparently a common practice with adulterated oils -- heretofore performed with no adverse reactions).  However, separate batches were refined and processed differently and also were diluted with different oils.  The exact contaminant and/or process that resulted in toxicant formation was never identified (the processes employed could not be duplicated) nor could the toxicity be reproduced in the laboratory.  The exact causative agent is still not know, nor will it probably ever be identified.  This case illustrates the importance of standard operating procedures for handling and processing foods and toxicity testing of ALL additives and end products.

Two additional cases of food contamination involve the use of mercurial fungicides to preserve grains that were used as food sources for livestock

END MATERIAL FOR TEST 2